Automated artificial intelligence-based system for clinical follow-up of patients with age-related macular degeneration.

The proposed autonomous follow-up system was shown to be safe and compliant with expert consensus on par with clinical practice. The system could in the future ease the pressure on public ophthalmology services from an increasing number of AMD patients.